Tune in to the live broadcast of the digital conference on multiple sclerosis, Wednesday June 26, 2024. Experts from the Institute will present the latest advances in this pathology, in particular new treatments.
There multiple sclerosis (MS) is a disease characterized by lesions affecting the brain or spinal cord: they form “plaques” in which the protective sheath of neurons, myelin, is destroyed. Within these lesions, inflammation leads to degeneration of neurons with a loss of communication between the brain and peripheral organs. MS is the 2e cause of acquired disability in young adults in France, after trauma. It affects 120,000 people with 3,000 new cases diagnosed each year.
Understanding and caring
This disease constitutes a major public health issue because it affects an active population, in the phase of building a life project with an average age of onset of 30 years. Experts at the Brain Institute are working to better understand the disease and find therapeutic solutions.
Access the conference live on Wednesday June 26 from 9:45 a.m. or on replay:
Conference program
- 9:45 a.m.: Introduction
By Professor Alexis Brice, Director General of the Brain Institute - 9:55 a.m.: “Multiple sclerosis: challenges to explore”
By Professor Benedetta Bodini, AP-HP neurologist and researcher in the “Remyelination in multiple sclerosis: from biology to clinical translation” team at the Brain Institute - 10:35 a.m.: “Status of research on MS and current projects within the Institute”
By Violetta Zujovic, Inserm researcher and co-leader of the “Plasticity and regeneration of myelin” team at the Brain Institute - 11:15 a.m.: “Healthy Mind, therapeutic virtual reality device to reduce pain and anxiety”
By Malo Louvigné, Chief Technical Officer (CTO) of the start-up
Healthy Mind which develops research projects in collaboration with the Brain Institute
SCIENTIFIC TEAMS:
Remyelination in multiple sclerosis: from biology to clinical translation
Myelin plasticity and regeneration
Teams scientists
“Remyelination in multiple sclerosis: from biology to clinical translation” team
Catherine LUBETZKI
MD, PhD, PU-PH, Sorbonne University, AP-HP
Bruno STANKOFF
MD, PhD, PU-PH, Sorbonne University, AP-HP
Repair
Main field: molecular and cellular neuroscience
Secondary area: Clinical and translational neuroscience
The team “Remyelination in multiple sclerosis: from biology to clinical translation”, led by Catherine LUBETZKI & Bruno STANKOFF, is interested in the mechanisms of myelin repair in the brain and spinal cord in multiple sclerosis. plaques and demyelinating diseases.
Read more
